QR-Bromocriptine as an Adjunct to Insulin and Metformin in the Treatment of Type 2 Diabetes.
Phase of Trial: Phase IV
Latest Information Update: 15 Jun 2015
At a glance
- Drugs Bromocriptine (Primary) ; Insulin; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 15 Jun 2015 Primary endpoint of 'change in A1C% from baseline' has been met, according to a VeroScience media release.
- 15 Jun 2015 Results published in the Journal of Diabetes Research, according to a VeroScience media release.
- 28 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.